文献速递血栓与止血

静脉血栓栓塞症的长期治疗策略

Long-term treatment of venous thromboembolism.
PubMed 文献 · Blood · 2020-01-01

本文综述了静脉血栓栓塞症(VTE)长期抗凝时长的决策依据,指出一过性诱因或首次孤立远端深静脉血栓(DVT)一般抗凝3个月,持续或进展性危险因素(如癌症)或二次特发性近端DVT/肺栓塞(PE)一般无限期抗凝。首次特发性近端DVT或PE可治疗3至6个月或无限期,男性、PE表现、停抗凝后d-二聚体阳性、抗磷脂抗体、低出血风险及患者意愿支持无限期抗凝。

要点

  • 一过性诱因或首次孤立远端DVT一般抗凝3个月。
  • 持续/进展性危险因素或二次特发性近端DVT/PE一般无限期抗凝。
  • 低剂量口服Xa抑制剂方便且出血风险较低,但复发风险高者不太适合。

核心结论

  • VTE长期治疗的核心决策是抗凝时长,依据诱因是否可逆、血栓部位及复发危险因素个体化确定。

研究设计与样本

  • 综述,未报告检索范围与样本量。

主要发现

  • 一过性诱因或首次孤立远端DVT一般抗凝3个月;持续或进展性危险因素或二次特发性近端DVT/PE一般无限期抗凝。
  • 首次特发性近端DVT或PE可治疗3至6个月或无限期。
  • 男性、PE表现(尤其合并近端DVT)、停抗凝后d-二聚体阳性、抗磷脂抗体、低出血风险及患者意愿支持无限期抗凝。

关键数值与推荐

  • 低剂量口服Xa抑制剂方便且被认为出血风险较低,但复发风险较高时不太适合。
  • 癌症相关VTE优先选择全剂量口服Xa抑制剂而非低分子肝素,胃肠道病变为相对禁忌。
  • DVT后不常规推荐梯度压力袜,但持续腿部肿胀或试用后症状改善者鼓励使用。
  • PE后应临床监测慢性血栓栓塞性肺动脉高压(CTEPH),疑诊时初始诊断检查为通气-灌注扫描和超声心动图。

临床怎么用

  • 根据诱因可逆性、血栓部位及复发危险因素决定抗凝时长。
  • 无限期抗凝时药物类型次要,低剂量Xa抑制剂方便但需评估复发风险。
  • 癌症相关VTE优先全剂量口服Xa抑制剂,胃肠道病变相对禁忌。
  • PE后监测CTEPH,疑诊时行通气-灌注扫描和超声心动图。
  • CTEPH及有症状的广泛残余灌注缺损者应评估内膜剥脱术、球囊肺动脉成形术或血管扩张剂治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most important decision in the long-term treatment of venous thromboembolism (VTE) is how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked isolated distal deep vein thrombosis (DVT), generally should be treated for 3 months. VTE provoked by a persistent or progressive risk factor (eg, cancer), or a second unprovoked proximal DVT or PE, is generally treated indefinitely. First unprovoked proximal DVT or PE may be treated for 3 to 6 months or indefinitely. Male sex, presentation as PE (particularly if concomitant proximal DVT), a positive d-dimer test after stopping anticoagulation, an antiphospholipid antibody, low risk of bleeding, and patient preference favor indefinite anticoagulation. The type of indefinite anticoagulation is of secondary importance. Low-dose oral Xa inhibitors are convenient and are thought to have a lower risk of bleeding; they are less suitable if there is a higher risk for recurrence. For cancer-associated VTE, we now prefer full-dose oral Xa inhibitors over low-molecular-weight heparin, with gastrointestinal lesions being a relative contraindication. Graduated compression stockings are not routinely indicated after DVT, but are encouraged if there is persistent leg swelling or if a trial of stockings improves symptoms. Medications have a limited role in the treatment of postthrombotic syndrome. After PE, patients should have clinical surveillance for chronic thromboembolic pulmonary hypertension (CTEPH), with ventilation-perfusion scanning and echocardiography being the initial diagnostic tests if CTEPH is a concern. Patients with CTEPH and other symptomatic patients with extensive residual perfusion defects should be evaluated for endarterectomy, balloon pulmonary angioplasty, or vasodilator therapies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kearon C, Kahn SR. Long-term treatment of venous thromboembolism. Blood. 2020. PMID: 31917402. doi:10.1182/blood.2019002364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。